0.2050
+0.0060
+(3.02%)
At close: January 10 at 8:06:00 AM GMT+1
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2020) | Next Qtr. (Jun 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2020) | Next Qtr. (Jun 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2020) | Next Qtr. (Jun 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2020) | Next Qtr. (Jun 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 041.SG | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
IUGNF Imugene Limited
0.0290
-3.65%
LIXT Lixte Biotechnology Holdings, Inc.
2.5900
+12.61%
KRRO Korro Bio, Inc.
35.26
-6.27%
LYEL Lyell Immunopharma, Inc.
0.6040
-7.32%
MDXG MiMedx Group, Inc.
8.65
-2.26%
PHIO Phio Pharmaceuticals Corp.
1.6900
0.00%
APTO Aptose Biosciences Inc.
0.2200
+3.19%
PCVX Vaxcyte, Inc.
81.08
+0.02%
XCUR Exicure, Inc.
9.46
+5.23%
AMLX Amylyx Pharmaceuticals, Inc.
3.5000
-7.16%